Profoject Safety Sliding Blood Collection Set
CMT Health PTE., Ltd. · Decision date Sep 25, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-09-25 for the Profoject™ Safety Sliding Blood Collection Set, submitted by CMT Health PTE., Ltd. of Singapore under 510(k) number K262215. The application was received 06/30/2026 as a traditional 510(k) reviewed by FDA rather than a third party, and it is not recorded as a combination product or as having an authorized predetermined change control plan. SESE means the device was cleared for marketing through the 510(k) pathway; it is not a PMA approval.
The device falls under regulation 862.1675, device classification name Tubes, Vials, Systems, Serum Separators, Blood Collection, with classification product code JKA, subsequent product code FPA, Clinical Chemistry specialty and General Hospital review panel. The record does not identify a predicate device, describe the sliding safety component, or include a summary statement, so the specific technological comparison supporting equivalence is not available here. Monica Ma is listed as applicant and correspondent contact.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262215
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- CMT Health PTE., Ltd.
- Product code
- JKA
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tubes, Vials, Systems, Serum Separators, Blood Collection.
- Applicant
- CMT Health PTE., Ltd.
- Product code
- JKA
- FDA device class
- 2
FDA decision timeline
K262215 received
Application receipt date recorded by FDA.
K262215 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JKA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CMT Health PTE., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Sol-Millennium Medical, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
| Becton Dickinson and Company | 510(k) clearance | Oct 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
CMT Health PTE., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Singapore
Sources and methodology
- Original FDA record: K262215
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

